Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Multicentre Phase II Study to Evaluate the Combination of Rituximab and DepoCyte [cytarabine] by Intrathecal Injection in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-Cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Next Previous
X
Search
Trial Profile

Prospective Multicentre Phase II Study to Evaluate the Combination of Rituximab and DepoCyte [cytarabine] by Intrathecal Injection in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-Cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cytarabine (Primary) ; Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Folinic acid; Methotrexate; Prednisolone; Vincristine
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 21 Aug 2018 Status changed from active, no longer recruiting to completed.
    • 03 Jul 2012 Baxter International, Dakota Pharm, Merck, Pfizer, Roche, Sandoz, SkyePharma PLC added as associations as reported in the European Clinical Trials Database record.
    • 03 Jul 2012 Additional trial location (Belgium) added as reported by European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top